These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 5391587)

  • 21. Contact phase of coagulation in diabetes mellitus after aspirin administration.
    Patrassi GM; Martinelli S; Picchinenna A; Girolami A
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1985; 112(2):333-8. PubMed ID: 2410343
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The relation of 'Fletcher Factor' to factors XI and XII.
    Hathaway WE; Alsever J
    Br J Haematol; 1970 Feb; 18(2):161-9. PubMed ID: 5439523
    [No Abstract]   [Full Text] [Related]  

  • 23. Preparation of 'contact product' as a reagent for coagulation tests.
    Pérez-Requejo JL; Ingram GI
    J Clin Pathol; 1975 Jul; 28(7):596-9. PubMed ID: 239026
    [No Abstract]   [Full Text] [Related]  

  • 24. A serial study of coagulation factors XII, XI and X in plasma in normal pregnancy and in pregnancy complicated by pre-eclampsia.
    Condie RG
    Br J Obstet Gynaecol; 1976 Aug; 83(8):636-9. PubMed ID: 952795
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Artificial deficient plasma for the determination of the activity of coagulation factor XI].
    Lutze G; Dieckmann U; Urbahn H
    Z Med Lab Diagn; 1984; 25(8):427-31. PubMed ID: 6523998
    [No Abstract]   [Full Text] [Related]  

  • 26. Defective activation of clotting, fibrinolytic, and permeability-enhancing systems in human Fletcher trait plasma.
    Saito H; Ratnoff OD; Donaldson VH
    Circ Res; 1974 May; 34(5):641-51. PubMed ID: 4826936
    [No Abstract]   [Full Text] [Related]  

  • 27. Identity of contact activation cofactor and Fitzgerald factor.
    Schiffman S; Lee P; Waldmann R
    Thromb Res; 1975 May; 6(5):451-4. PubMed ID: 237340
    [No Abstract]   [Full Text] [Related]  

  • 28. Studies on the product of the reaction between activated Hageman factor (factor XII) and plasma thromboplastin antecedent (factor XI).
    Ratnoff OD
    J Lab Clin Med; 1972 Nov; 80(5):704-10. PubMed ID: 4673237
    [No Abstract]   [Full Text] [Related]  

  • 29. Inhibition of activated Hageman factor and activated plasma thromboplastin antecedent by purified serum C1 inactivator.
    Forbes CD; Pensky J; Ratnoff OD
    J Lab Clin Med; 1970 Nov; 76(5):809-15. PubMed ID: 5477337
    [No Abstract]   [Full Text] [Related]  

  • 30. Specific coagulation factor adsorption as related to functional groups on surfaces.
    Oja PD; Holmes GW; Perkins HA; Love J
    J Biomed Mater Res; 1969 Mar; 3(1):165-74. PubMed ID: 5784962
    [No Abstract]   [Full Text] [Related]  

  • 31. Contact product in experimental intravascular activation of the clotting system.
    Altman R; Rouvier J; Daldin J
    Rev Bras Pesqui Med Biol; 1973; 6(5):223-8. PubMed ID: 4774622
    [No Abstract]   [Full Text] [Related]  

  • 32. Coagulation changes during massive hepatic necrosis due to Amanita phalloides poisoning with special reference to antihemophilic globulin.
    Meili EO; Frick PG; Straub PW
    Helv Med Acta; 1970 Oct; 35(4):304-13. PubMed ID: 5507041
    [No Abstract]   [Full Text] [Related]  

  • 33. Platelets and initiation of intrinsic clotting.
    Schiffman S; Rapaport SI; Chong MM
    Br J Haematol; 1973 May; 24(5):633-42. PubMed ID: 4712832
    [No Abstract]   [Full Text] [Related]  

  • 34. A simple screening test for evaluating prolonged partial thromboplastin times in newborn infants.
    Andrew M; Karpatkin M
    J Pediatr; 1982 Oct; 101(4):610-2. PubMed ID: 7119968
    [No Abstract]   [Full Text] [Related]  

  • 35. Fitzgerald factor: a hitherto unrecognised coagulation factor.
    Waldmann R; Abraham JP; Rebuck JW; Caldwell J; Saito H; Ratnoff OD
    Lancet; 1975 Apr; 1(7913):949-51. PubMed ID: 48123
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A simple method for induction of acute thrombocytopenia.
    Kraytman M
    J Lab Clin Med; 1969 Feb; 73(2):350-4. PubMed ID: 5764032
    [No Abstract]   [Full Text] [Related]  

  • 37. Partial thromboplastin time in the presence of heparin: a rapid polybrene neutralization method.
    Israels ED
    Am J Clin Pathol; 1982 Mar; 77(3):321-4. PubMed ID: 6803572
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Blood coagulation. Role of Hageman protein (F-XII) and autoprothrombin II (F-IX?) in the activation of autoprothrombin 3 (F-X).
    Seegers WH; Grammens GL; McCoy LE
    Thromb Diath Haemorrh; 1970 Dec; 24(3):345-51. PubMed ID: 5533980
    [No Abstract]   [Full Text] [Related]  

  • 39. The enigma of severe factor XI deficiency without hemmorrhagic symptoms. Distinction from Hageman factor and "Fletcher factor" deficiency; family study; and problems of diagnosis.
    Edson JR; White JG; Krivit W
    Thromb Diath Haemorrh; 1967 Dec; 18(3-4):342-8. PubMed ID: 5590232
    [No Abstract]   [Full Text] [Related]  

  • 40. Blood coagulation: comparative studies in dogs, cats, horses and cattle.
    Osbaldiston GW; Stowe EC; Griffith PR
    Br Vet J; 1970 Oct; 126(10):512-21. PubMed ID: 5491587
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.